Financial insights of VCYT

MyFinsight

For the year ending 2025-12-31, VCYT made $517,145K in revenue. $66,353K in net income. Net profit margin of 12.83%.

Income Statement	2025-12-31	2024-12-31
Total revenue	517,145	432,611
Cost of revenue-Testing	127,562	-
Cost of revenue-Product	8,807	-
Cost of revenue	-	136,067
Cost of revenue-Biopharmaceutical And Other	7,578	-
Intangible asset amortization - cost of revenue	10,666	11,552
Total cost of revenue	154,613	147,619
Gross profit	362,532	298,145
Research and development	70,814	69,294
Selling and marketing	100,165	95,434
General and administrative	110,784	110,610
Impairment of assets	20,505	3,368
Intangible asset amortization - operating expenses	-	3,297
Intangible asset amortization - operating expenses-Intangible Asset Amortization	2,487	-
Total operating expenses	304,755	282,003
Income (loss) from operations	57,777	16,142
Other income, net	10,424	9,602
Income (loss) before income taxes	68,201	25,744
Income tax provision (benefit)	1,848	1,606
Net income (loss)	66,353	24,138

Basic EPS	0.84	0.32
Diluted EPS	0.82	0.31
Basic Average Shares	78,584,291	76,484,759
Diluted Average Shares	80,573,140	78,163,217